Management of Signs and Symptoms Associated With Dry Eye Disease

Stopped early · Not applicable

Conditions studied: Dry Eye Syndromes

In brief

A prospective randomized, and controlled study to compare the effectiveness of PROKERA® SLIM plus standard of care (SOC) in the PROKERA® SLIM Arm to SOC alone in the Control Arm. Subjects presenting with moderate DED defined as corneal fluorescein staining score of ≥ 3 points out of 9 will be recruited.

Key facts

Study ID

NCT04015219

Run by

BioTissue Holdings, Inc

People needed

3

Starts

2018-07-18

Expected to finish

2020-10-05

Last updated by the study team

2022-12-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with moderate dry eye defined as corneal fluorescein staining score of ≥ 3
• Age ≥ 18 years
• Distance best corrected visual acuity better than 20/60 Snellen equivalent in each eye
• Willing to sign a written informed consent to participate
• Able to follow study instructions, with the intention of completing all required visits

You may not qualify if…

• Presence of persistent corneal epithelial defect or ulcer in either eye
• Presence of active ocular infection in either eye
• Presence of ocular inflammation that is not related to keratoconjunctivitis sicca, e.g., allergy, severe blepharitis
• Presence of other corneal disorder(s) that give rise to reduced corneal sensitivity, such as recurrent herpes keratitis
• Presence of corneal diseases other than dry eye that can disturb the pre-corneal tear film such as epithelial basement membrane dystrophy (EBMD)
• Contact lens wear
• History of recent ocular surgery/trauma, which could affect corneal sensitivity, e.g., corneal transplantation, LASIK
• Presence of cicatricial ocular surface diseases
• A medical or ocular condition, or a personal situation, which in the principal investigator's opinion, is not appropriate for participation in the trial
• Any scheduled or planned ocular or systemic surgery or procedure during the study
• Pregnancy and women who are expecting to be pregnant.
• Current enrolment in another interventional drug or device study or participation in such a study within 30 days of anticipated entry into this study

Where it is running

• Center of Excellence in Eye Care — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.